中华神经医学杂志
中華神經醫學雜誌
중화신경의학잡지
CHINESE JOURNAL OF NEUROMEDICINE
2011年
4期
356-359
,共4页
贺华%陶帮宝%胡国汉%骆纯%李兵%王君玉%卢亦成
賀華%陶幫寶%鬍國漢%駱純%李兵%王君玉%盧亦成
하화%도방보%호국한%락순%리병%왕군옥%로역성
RNA,小分子干扰%神经胶质瘤%MEK2%真核表达载体
RNA,小分子榦擾%神經膠質瘤%MEK2%真覈錶達載體
RNA,소분자간우%신경효질류%MEK2%진핵표체재체
RNA,small interfering%Glioma%MEK2%Eukaryotic expression vector
目的 构建MEK2-siRNA表达质粒,转染胶质瘤U87细胞并研究其对内源性MEK2表达的敲减效果.方法 化学合成4条60个碱基并能转录siRNA发卡结构的DNA寡核苷酸,退火形成2条双链DNA,以T4连接酶接入BglⅡ和HindⅢ双酶切后的pSUPER.basic载体中.EcoRⅠ和HindⅢ双酶切鉴定出阳性重组克隆,抽提质粒并转染胶质瘤U87细胞,Western blotting检测MEK2蛋白的表达水平.结果 酶切鉴定和测序结果表明MEK2-siRNA质粒构建成功,Western blotting结果筛选出较好的MEK2-siRNA质粒.未转染阴性对照质粒MEK2表达水平为0.105±0.023,转染筛选质粒后表达水平为0.030±0.006.结论 成功构建了MEK2-siRNA真核表达载体,并证明其能下调胶质瘤U87细胞中MEK2蛋白的表达水平,为RNA干扰技术应用于胶质瘤的基因治疗提供了一定的实验依据.
目的 構建MEK2-siRNA錶達質粒,轉染膠質瘤U87細胞併研究其對內源性MEK2錶達的敲減效果.方法 化學閤成4條60箇堿基併能轉錄siRNA髮卡結構的DNA寡覈苷痠,退火形成2條雙鏈DNA,以T4連接酶接入BglⅡ和HindⅢ雙酶切後的pSUPER.basic載體中.EcoRⅠ和HindⅢ雙酶切鑒定齣暘性重組剋隆,抽提質粒併轉染膠質瘤U87細胞,Western blotting檢測MEK2蛋白的錶達水平.結果 酶切鑒定和測序結果錶明MEK2-siRNA質粒構建成功,Western blotting結果篩選齣較好的MEK2-siRNA質粒.未轉染陰性對照質粒MEK2錶達水平為0.105±0.023,轉染篩選質粒後錶達水平為0.030±0.006.結論 成功構建瞭MEK2-siRNA真覈錶達載體,併證明其能下調膠質瘤U87細胞中MEK2蛋白的錶達水平,為RNA榦擾技術應用于膠質瘤的基因治療提供瞭一定的實驗依據.
목적 구건MEK2-siRNA표체질립,전염효질류U87세포병연구기대내원성MEK2표체적고감효과.방법 화학합성4조60개감기병능전록siRNA발잡결구적DNA과핵감산,퇴화형성2조쌍련DNA,이T4련접매접입BglⅡ화HindⅢ쌍매절후적pSUPER.basic재체중.EcoRⅠ화HindⅢ쌍매절감정출양성중조극륭,추제질립병전염효질류U87세포,Western blotting검측MEK2단백적표체수평.결과 매절감정화측서결과표명MEK2-siRNA질립구건성공,Western blotting결과사선출교호적MEK2-siRNA질립.미전염음성대조질립MEK2표체수평위0.105±0.023,전염사선질립후표체수평위0.030±0.006.결론 성공구건료MEK2-siRNA진핵표체재체,병증명기능하조효질류U87세포중MEK2단백적표체수평,위RNA간우기술응용우효질류적기인치료제공료일정적실험의거.
Objective To construct a eukaryotic expression vector for MEK2-siRNA to explore the expression of this endogenous MEK2 in glioma U87 cell line. Methods Four single-stranded template DNAs encoding siRNA against MEK2, each consisting of 60 bp, were synthesized chemically;based on these 4 single-stranded template DNAs, 2 double-stranded DNAs were formed by annealing,then identified by restriction analysis and inserted into vector pSUPER.basic by T4 ligase. Positive recombinants were indentified by EcoRI and HindⅢ double digestion and transfected into the U87 cells.The protein expression level of MEK2 was determined by using Western blotting. Results Both restriction analysis and sequencing proved that the eukaryotic expression vector for MEK2-siRNA was constructed correctly. MEK2-siRNA plasmid screened out by Western blotting. The MEK2 expression level in negative control group was (0.105±0.023) and that in transfected group was (0.030±0.006).Conclusion The eukaryotic expression vector for MEK2-siRNA is successfully constructed, which down-regulates the transcription of MEK2 protein in U87 cells. It provides a certain experimental basis for gene therapy of glioma by RNAi technique.